Ryan Matt, Briceno Natalia, Perera Divaka
School of Cardiovascular Medicine and Sciences, King's College London, London, UK.
Korean Circ J. 2019 Mar;49(3):197-213. doi: 10.4070/kcj.2018.0443.
Despite the development of acute revascularisation, the mortality rate for cardiogenic shock remains around 50%. Mechanical circulatory support devices have long held promise in improving outcomes in shock, but high-quality evidence of benefit has not been forthcoming. In this article we review the currently available devices for treating shock, their physiological effects and the evidence base for their use in practice. We subsequently look ahead within this developing field, including new devices and novel indications for established technology.
尽管急性血管重建技术有所发展，但心源性休克的死亡率仍保持在50%左右。长期以来，机械循环支持设备一直有望改善休克患者的预后，但尚未有高质量的获益证据。在本文中，我们回顾了目前可用于治疗休克的设备、它们的生理效应以及在实际应用中的证据基础。随后，我们展望了这一不断发展的领域，包括新设备和现有技术的新适应症。
